TheraRadar
← Back
Data updated: Mar 29, 2026

MEITHEAL

OncologyInfectious DiseaseCardiovascular
Generics

MEITHEAL is a generic drug manufacturer focused on Oncology, Infectious Disease, Cardiovascular. Key products include CONTEPO.

1993
Since
69
Drugs
-
Trials
380
Approved (2yr)

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 50%
16 drugs
Infectious Disease 19%
6 drugs
Cardiovascular 16%
5 drugs
Dermatology 9%
3 drugs
Respiratory 6%
2 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...